Sunday, August 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth AcceleratestodayMarketHugel Posts Record H1 Revenue on Overseas Toxin Surge3 days agoDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion DemandtodayMarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%3 days agoInjectablesGalderma Wins EU Nod for Restylane ShaypeyesterdayBusiness & M&AEstablishment Labs Raises 2026 Revenue Guidance2 days agoDevices & TechMerz Ultherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&ABeauty Health Q2 Earnings: Device Demand Steady2 days agoInjectablesHugel Debuts Thechaum Signature with Reduced CrosslinkeryesterdayDevices & TechAlma Launches TitaniumLift™ Multi-Depth RF Protocol2 days agoInjectablesGLP-1 Boom Exposed Filler Limitations—Here's WhyyesterdayInjectablesGalderma Chief: Start GLP-1 Patients on Skin Care First2 days ago
Markets & Filings

Form 4

The near-real-time disclosure of insider stock buys and sells by executives, directors, and big holders.

Also known as: Insider Transaction, Section 16 Filing

What it is
A Form 4 reports transactions in a company's stock by insiders, officers, directors, and 10% owners, generally within two business days. It shows shares bought or sold, price, and remaining holdings. It is a Section 16 requirement.
What it does
Insider buying, especially open-market purchases by executives, is watched as a conviction signal, while clustered selling can flag concern. Investors screen Form 4s for meaningful, non-routine trades. Context (10b5-1 plans, option exercises) matters.
The evidence
Notable open-market insider purchases have preceded stock rallies and are tracked as sentiment signals.
Best for
Any single name; especially small and mid-caps where insiders own large stakes.
Pairs well with
8-k, 13f, catalyst
Use cautiously with
Sales are often for taxes or diversification under preset plans; reading all selling as bearish misfires.
Cautions
One insider trade is a weak signal on its own and needs corroboration.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo